A detailed history of Pay Pay Securities Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pay Pay Securities Corp holds 59 shares of BMY stock, worth $3,097. This represents 0.2% of its overall portfolio holdings.

Number of Shares
59
Previous 49 20.41%
Holding current value
$3,097
Previous $2.66 Million 7.79%
% of portfolio
0.2%
Previous 0.13%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$40.25 - $52.99 $402 - $529
10 Added 20.41%
59 $2.45 Million
Q1 2024

Apr 17, 2024

SELL
$47.98 - $54.4 $287 - $326
-6 Reduced 10.91%
49 $2.66 Million
Q4 2023

Jan 30, 2024

BUY
$48.48 - $57.85 $533 - $636
11 Added 25.0%
55 $2.83 Million
Q2 2023

Jul 27, 2023

SELL
$63.71 - $70.74 $764 - $848
-12 Reduced 21.43%
44 $2.81 Million
Q1 2023

Apr 20, 2023

SELL
$65.71 - $74.53 $2,825 - $3,204
-43 Reduced 43.43%
56 $3.88 Million
Q4 2022

Feb 02, 2023

BUY
$68.48 - $81.09 $6,779 - $8,027
99 New
99 $7.12 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $112B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pay Pay Securities Corp Portfolio

Follow Pay Pay Securities Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pay Pay Securities Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pay Pay Securities Corp with notifications on news.